The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369

GRADE guidelines: 3. Rating the quality of evidence

Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285

Clinical Practice Guidelines We Can Trust

Board on Health Care Services (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,146

Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III

Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0584 · Cited by 2,556

Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence: The COMBINE Study: A Randomized Controlled Trial

Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930

GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength

Andrews, J. C., Schünemann, H. J., Oxman, A. D., Pottie, K. C., Meerpohl, J. J., Alonso‐Coello, P., Rind, D. M., Montori, V. M., Brito, J. P., Norris, S. L., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.02.003 · Cited by 1,366

Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines

Guyatt, G., Gutterman, D., Baumann, M. H., Addrizzo-Harris, D., Hylek, E. M., Phillips, B., Raskob, G., Lewis, S. Z., & Schünemann, H. (2006) · Chest · doi:10.1378/chest.129.1.174 · Cited by 1,220

Economic costs of excessive alcohol consumption in the U.S., 2006

Bouchery, E. E., Harwood, H. J., Sacks, J. J., Simon, C. J., & Brewer, R. D. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.06.045 · Cited by 1,041 · cited 1×

Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty

Mark, T. L., Kassed, C. A., Vandivort-Warren, R., Levit, K. R., & Kranzler, H. R. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.07.018 · Cited by 246

Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. Project MATCH Research Group.

(1998) · Journal of Studies on Alcohol · doi:10.15288/jsa.1998.59.631 · Cited by 205

Carnitine in Alcohol Use Disorders: A Scoping Review

Bota, A. B., Simmons, J.-G., DiBattista, A., & Wilson, K. R. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14568 · Cited by 13

Brain Correlates of the Alcohol Use Disorder Pharmacotherapy Response: A Systematic Review of Neuroimaging Studies

Florence, L. L. A., Lassi, D. L. S., Kortas, G. T., Lima, D. R., Périco, C. D. A.-M., de Andrade, A. G., Torales, J. C., Ventriglio, A., Berardis, D. D., Aquino, J. P. D., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12030386 · Cited by 13

Alcohol reduction interventions for transgender and non-binary people: A PRISMA-ScR-adherent scoping review

Montemayor, A. S. C., & Connolly, D. J. (2023) · Addictive Behaviors · doi:10.1016/j.addbeh.2023.107779 · Cited by 16

Long-Acting Injectable Antipsychotic Treatment for Schizophrenia in Asian Population: A Scoping Review

Ma, N., Zhang, L., Zhang, W., He, Y., Ye, C., & Li, X. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s413371 · Cited by 13

Alcohol use disorder in the perioperative period: a summary and recommendations for anesthesiologists and pain physicians

Lane, O. P., Ambai, V. T., Bakshi, A., & Potru, S. (2023) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2023-104354 · Cited by 20

Closing the Care Gap: Management of Alcohol Use Disorder in Patients with Alcohol-associated Liver Disease

Green, E. W., Byers, I. S., & Deutsch‐Link, S. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.09.017 · Cited by 14

The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists

Imperio, C. G., LEVIN, F. R., & Martínez, D. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20231023 · Cited by 15

Alcohol Use Disorder Medication Coverage and Utilization Management in Medicaid Managed Care Plans

Stewart, M. T., Feltus, S. R., Andrews, C. M., Acevedo, A., Parks, C. L., Bratberg, J. P., Horgan, C. M., Hodgkin, D., & Adams, R. S. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.0695 · Cited by 13

A Novel Dual Drug Approach That Combines Ivermectin and Dihydromyricetin (DHM) to Reduce Alcohol Drinking and Preference in Mice

Silva, J., Carry, E., Chen, X., Zhang, J., Liang, J., Roberge, J. Y., & Davies, D. L. (2021) · Molecules · doi:10.3390/molecules26061791 · Cited by 13

The Need for Integrating Addiction Medicine and Hepatology

Leggio, L., & Jung, M. K. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.13022 · Cited by 13

The Added Value of Pharmacotherapy to Cognitive Behavior Therapy And Vice Versa in the Treatment of Alcohol Use Disorders: A Systematic Review

van Amsterdam, J., Blanken, P., Spijkerman, R., van den Brink, W., & Hendriks, V. M. (2022) · Alcohol and Alcoholism · doi:10.1093/alcalc/agac043 · Cited by 14

Pharmacogenetics of alcohol addiction: current perspectives

Zastrozhin, M. S., Skryabin, V. Y., Miroshkin, S., Bryun, E. A., & Sychev, D. A. (2019) · The Application of Clinical Genetics · doi:10.2147/tacg.s206745 · Cited by 13

Influence of combined treatment with naltrexone and memantine on alcohol drinking behaviors: a phase II randomized crossover trial

Krishnan‐Sarin, S., O’Malley, S. S., Franco, N., Cavallo, D. A., Tetrault, J. M., Shi, J. M., Gueorguieva, R. V., Pittman, B. P., & Krystal, J. H. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0536-z · Cited by 13

Efficacy of Pharmacological Interventions in Targeting Decision-Making Impairments across Substance and Behavioral Addictions

Chamberlain, S. R., & Grant, J. E. (2019) · Neuropsychology Review · doi:10.1007/s11065-019-09400-z · Cited by 16

Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy

Tarli, C., Mirijello, A., & Addolorato, G. (2022) · Seminars in Liver Disease · doi:10.1055/a-1798-2872 · Cited by 12

Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration

Taylor, E. N., Timko, C., Harris, A. H. S., Yu, M., & Finlay, A. K. (2019) · Addiction Science & Clinical Practice · doi:10.1186/s13722-018-0129-x · Cited by 12

Pharmacotherapy options for alcohol use disorder in patients with alcohol-associated liver disease: a brief guide for clinicians

Coe, C., Patel, A. A., & Lawrence, D. (2023) · Clinical Liver Disease · doi:10.1097/cld.0000000000000033 · Cited by 9

Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy

Minozzi, S., Ambrosi, L., Saulle, R., Uhm, S., Terplan, M., Sinclair, J., & Agabio, R. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015042.pub2 · Cited by 12

Medications for Alcohol Use Disorder: Rates and Predictors of Prescription Order and Fill in Outpatient Settings

Hodgkin, D., Busch, A. B., Kennedy‐Hendricks, A., Azeni, H., Horgan, C. M., Uscher‐Pines, L., & Huskamp, H. A. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-09002-3 · Cited by 11

Alcoholic Hepatitis

Penninti, P., Adekunle, A. D., & Singal, A. K. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.12.005 · Cited by 11

SAEM GRACE : Anti‐craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence

Punia, K., Scott, W., Manuja, K., Sabbineni, M., Campbell, K., Balodis, I. M., & MacKillop, J. M. (2023) · Academic Emergency Medicine · doi:10.1111/acem.14806 · Cited by 11

Gabapentin increases the abuse liability of alcohol alone and in combination with oxycodone in participants with co-occurring opioid and alcohol use disorder

Castillo, F., Jones, J. D., Luba, R. R., Mogali, S., Foltin, R. W., Evans, S. M., & Comer, S. D. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173482 · Cited by 10

Recommendations on the measurement and use of the alcohol consumption biomarker CDT. A position paper from the IFCC Working Group on CDT standardisation

Wielders, J. P. M., Porpiglia, N. M., Schellenberg, F., Deenmamode, J., Delanghe, J., Anton, R. F., Bortolotti, F., Siebelder, C., Tagliaro, F., Weykamp, C. W., et al. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.117800 · Cited by 10

Next‐generation biomarkers for alcohol consumption and alcohol use disorder diagnosis, prognosis, and treatment: A critical review

Clark, S. L., Hartwell, E. E., Choi, D., Krystal, J. H., Messing, R. O., & Ferguson, L. B. (2024) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15476 · Cited by 11

Modern pharmacotherapy guidance for treating alcohol use disorders

Soyka, M., & Rösner, S. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2445734 · Cited by 11

Time to Treat Alcohol Use Disorder in the Emergency Department

Hawk, K. F., & D’Onofrio, G. (2023) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2022.11.013 · Cited by 10

Brain activation and subjective anxiety during an anticipatory anxiety task is related to clinical outcome during prazosin treatment for alcohol use disorder

Wilcox, C. E., Adinoff, B. H., Clifford, J. M., Ling, J. M., Witkiewitz, K. A., Mayer, A. R., Boggs, K. M., Eck, M., & Bogenschutz, M. P. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102162 · Cited by 11

Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis

Rogal, S. S., Youk, A. O., Agbalajobi, O. M., Zhang, H., Gellad, W. F., Fine, M. J., Belperio, P. S., Morgan, T. R. M., Good, C. B., & Kraemer, K. L. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001228 · Cited by 10

Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with alcohol use disorder: a case report

Deng, H., Benhamou, O.-M. J., & Lembke, A. (2021) · Journal of Addictive Diseases · doi:10.1080/10550887.2021.1907502 · Cited by 10

Knowledge atlas of the involvement of glutamate and GABA in alcohol use disorder: A bibliometric and scientometric analysis

Wang, Z., Zhu, X., Ni, X., Wen, Y., & Shang, D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.965142 · Cited by 10

Therapeutic Pipeline in Alcohol-Associated Liver Disease

Thakral, N., Deutsch‐Link, S., & Singal, A. K. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1759614 · Cited by 12

Management of Sedation and Analgesia in Critically Ill Patients Receiving Long-Acting Naltrexone Therapy for Opioid Use Disorder

Petri, C. R., & Richards, J. B. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202005-554cme · Cited by 11

Salutogenic Architecture, Non-Therapeutic Environments and the Health of the Elderly: A Systematic Review

Rakhshani, Z., & Khakzand, M. (2025) · HERD Health Environments Research & Design Journal · doi:10.1177/19375867251313980 · Cited by 9

Patient perspectives on medications for alcohol use disorder: A systematic scoping review

Tomlinson, D. C., Florimbio, A. R., Lee, C. A., Ilgen, M. A., Lin, L. A., & Coughlin, L. N. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70022 · Cited by 9

Combined pharmacological and psychosocial interventions for alcohol use disorder

Minozzi, S., Rosa, G. R. M. L., Salis, F., Camposeragna, A., Saulle, R., Leggio, L., & Agabio, R. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015673.pub2 · Cited by 10

Veteran adherence to oral versus injectable AUD medication treatment

Stewart, H., Mitchell, B. G., Ayanga, D., & Walder, A. M. (2021) · Mental Health Clinician · doi:10.9740/mhc.2021.05.194 · Cited by 9

Treatment for alcohol use disorder among persons with and without HIV in a clinical care setting in the United States

Davy-Méndez, T., Sarovar, V., Levine‐Hall, T., Lea, A. N., Sterling, S., Chi, F. W., Palzes, V. A., BRYANT, K. J., Weisner, C. M., Silverberg, M. J., et al. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.109110 · Cited by 9

Guidelines for integrating spirituality into the prevention and treatment of alcohol and other substance use disorders

de Rezende-Pinto, A., & Moreira‐Almeida, A. (2023) · Brazilian Journal of Psychiatry · doi:10.47626/1516-4446-2022-2984 · Cited by 9

Treatment of the Alcohol Use Disorder at Outpatient Psychiatric Clinic

Joe, K. H. (2019) · 신경정신의학 · doi:10.4306/jknpa.2019.58.3.159 · Cited by 9

Alcohol Reduction to Reduce Relapse in Acute Alcoholic Pancreatitis—Missed Opportunities

Sissingh, N. J., Umans, D. S., Goudriaan, A. E., Sijbom, M., Verdonk, R. C., van Hooft, J. E., & for the Dutch Pancreatitis Study Group (2021) · Alcohol and Alcoholism · doi:10.1093/alcalc/agab014 · Cited by 9

Approaching Alcohol Use Disorder After Liver Transplantation for Acute Alcoholic Hepatitis

Ting, P., Gurakar, A. O., Wheatley, J., Chander, G., Cameron, A. M., & Chen, P. (2021) · Clinics in Liver Disease · doi:10.1016/j.cld.2021.03.008 · Cited by 10

Stigmatizing Terminology for Outcomes and Processes (STOP) in Alcohol Research: A Meta-epidemiologic Assessment of Language Used in Clinical Trial Publications

Hartwell, M. L., Lin, V., Hester, M., Sajjadi, N. B., Dunn, K., Morris, J., & Witkiewitz, K. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000960 · Cited by 9

Medication treatment for alcohol use disorder in special populations

Malhotra, A., Drexler, K. P. G., Hsu, M., & Tang, Y. (2023) · American Journal on Addictions · doi:10.1111/ajad.13455 · Cited by 9

Understanding motivations and use typologies of gabapentin with opioid agonist medications

Ellis, M. S., Qureshi, R., & Buttram, M. E. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109713 · Cited by 8

Patient perspectives on emergency department initiation of medication for alcohol use disorder

Forsgren, E., Steiger, A., Perez, Y., Salazar, D. A. R., McCollough, M., & Taira, B. R. (2023) · Academic Emergency Medicine · doi:10.1111/acem.14758 · Cited by 8

Treatment of Alcohol Use Disorder

Tareen, K., Clifton, E. G., Perumalswami, P., Mellinger, J. L., & Winder, G. S. (2024) · Clinics in Liver Disease · doi:10.1016/j.cld.2024.06.011 · Cited by 9

Alcohol-Associated Liver Disease: Managing the Dual Pathology of Liver Disease and of Alcohol Use Disorder

Arab, J. P., Louvet, A., Thiele, M. S., Winder, G. S., Wong, R. J., & Singal, A. K. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.09.042 · Cited by 8

Pharmacological Treatments in Alcohol Use Disorder and Risk of Alcohol‐Related Hospitalizations: A Register Study

Bach, P., Franck, J., Hällgren, J., Widing, H., Gissler, M., & Westman, J. (2025) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13802 · Cited by 8

Alcohol use disorder and body mass index show genetic pleiotropy and shared neural associations

Malone, S. G., Davis, C. N., Piserchia, Z., Setzer, M. R., Toikumo, S., Zhou, H., Winterlind, E. L., Gelernter, J. E., Justice, A. C., Leggio, L., et al. (2025) · Nature Human Behaviour · doi:10.1038/s41562-025-02148-y · Cited by 9

Disulfiram induces redox imbalance and perturbations in central glucose catabolism and metal homeostasis to inhibit the growth of Staphylococcus aureus

Long, T. E., Naidu, S. T., Hissom, E. G., Meka, Y., Chavva, H., Brown, K. C., Valentine, M. E., Fan, J., Denvir, J., Primerano, D. A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-00078-3 · Cited by 8

Evidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology

Sinclair, J., Kalk, N. J., Kaar, S. J., Agabio, R., Arunogiri, S., Bisaga, A. M., Chesney, E., Daly, C., Dewhurst, J., Freeman, T. P., et al. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811251399593 · Cited by 10

Relationship Between Primary Care Providers’ Perceptions of Alcohol Use Disorder And Pharmacotherapy Prescribing Rates

Bernstein, E. Y., Pfoh, E. R., Le, P., & Rothberg, M. B. (2022) · Alcohol and Alcoholism · doi:10.1093/alcalc/agac057 · Cited by 8

Delving into the reducing effects of the GABAB positive allosteric modulator, KK-92A, on alcohol-related behaviors in rats

Maccioni, P., Kaczanowska, K., Lobina, C., Somenzi, L. R., Bassareo, V., Gessa, G. L., Lawrence, H. R., McDonald, P. H., & Colombo, G. (2023) · Alcohol · doi:10.1016/j.alcohol.2023.07.004 · Cited by 8

Acceptability of pharmacotherapy for hazardous alcohol use among men who have sex with men: Findings from a qualitative study

Hsiang, E., Jennings, D., Matheson, T., Hern, J., Euren, J., & Santos, G. (2018) · Addictive Behaviors Reports · doi:10.1016/j.abrep.2018.09.004 · Cited by 8

Gabapentin for Alcohol-Related Disorders

Andrade, C. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.20f13775 · Cited by 8

Psychobiotic interventions attenuate chronic alcohol use-mediated exacerbation of posttraumatic stress disorder in rats: the role of gut-liver axis response

Akinluyi, E. T., Edem, E. E., Dakoru, K. M., Nnodim, C. J., Oladipupo, M. A., Adeoluwa, O. A., Obisesan, A. O., Ben‐Azu, B., & Adebayo, O. G. (2022) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2022-0353 · Cited by 8

An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trial

Votaw, V. R., Witkiewitz, K. A., Horn, M. L. V., Crist, R. C., Pond, T., & Kranzler, H. R. (2023) · Addiction · doi:10.1111/add.16126 · Cited by 8

Effects of Mindfulness-Based Relapse Prevention Therapy on Drug Craving and Emotion Regulation of Therapeutic Community Centers Clients

Hosseini, P. S., Saadi, Z. E., & Fard, R. J. (2023) · Journal of Health Reports and Technology · doi:10.5812/jhrt-136888 · Cited by 7

Effects of Alcohol Withdrawal on Sleep Macroarchitecture and Microarchitecture in Female and Male Rats

Jones, M., Brandner, A. J., Vendruscolo, L. F., Vendruscolo, J. C. M., Koob, G. F., & Schmeichel, B. E. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.838486 · Cited by 7

The use of medications approved for alcohol use disorders in Italy

Fortinguerra, F., Pierantozzi, A., & Trotta, F. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1110435 · Cited by 7

Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder

Castaldelli-Maia, J. M., Malbergier, A., OLIVEIRA, A. B., do Amaral, R. A., Negrão, A. B., Gonçalves, P. D., Ventriglio, A., Berardis, D. D., Antonio, J. D., Firigato, I., et al. (2021) · Biomolecules · doi:10.3390/biom11101495 · Cited by 7

Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis

Patidar, K. R., Ortiz, M. G., Slaven, J. E., Nephew, L. D., Vilar‐Gómez, E., Kettler, C. D., Ghabril, M., Desai, A. P., Orman, E. S., Chalasani, N., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000341 · Cited by 7

Repurposing drugs for treatment of alcohol use disorder

Aubin, H. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.02.002 · Cited by 6

Clinical Presentations and Treatment of Baclofen Toxicity and Withdrawal: A Systematic Review

Iqbal, M., Modi, P., Sehgal, K., Costa, G. P. A., Bhattacharya, G., Nero, N., Siddiqui, J., Weleff, J., & Anand, A. (2026) · CNS Drugs · doi:10.1007/s40263-025-01254-9 · Cited by 7

The global epidemiology of alcohol-associated liver disease

Danpanichkul, P., Idalsoaga, F. J., Murray, F., Arab, J. P., & Díaz, L. A. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000000947 · Cited by 6

Improving the utilisation of medication-assisted treatment for alcohol use disorder at discharge

Arms, L., Johl, H., & DeMartini, J. (2022) · BMJ Open Quality · doi:10.1136/bmjoq-2022-001899 · Cited by 6

Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) of the Bed Nucleus of the Stria Terminalis Mediates Heavy Alcohol Drinking in Mice

Lepeak, L., Miracle, S. A., Ferragud, A., Seiglie, M. P., Shafique, S., Öztürk, Z., Minnig, M. A., Medeiros, G., Cottone, P., & Sabino, V. (2023) · eNeuro · doi:10.1523/eneuro.0424-23.2023 · Cited by 6

Randomized Controlled Trial of Bifrontal Transcranial Direct Current Stimulation on Craving in Alcohol Use Disorder

Gairola, A., Nischal, A., Kar, S. K., Arya, A., & Singh, A. K. (2024) · Indian Journal of Psychological Medicine · doi:10.1177/02537176231223314 · Cited by 7

Interventions for Pancreatitis—New Approaches, Knowledge Gaps, and Research Opportunities

Phillips, A. E., Hughes, S. J., Andersen, D. K., Bell, A., Brand, R. E., Coté, G. A., Cowdin, A., Diazgranados, N., Dudeja, V., Duggan, S. N., et al. (2024) · Pancreas · doi:10.1097/mpa.0000000000002333 · Cited by 6

The Safety of Alcohol Pharmacotherapies in Pregnancy: A Scoping Review of Human and Animal Research

Quintrell, E., Russell, D. J., Rahmannia, S., Wyrwoll, C. S., Larcombe, A. N., & Kelty, E. A. (2024) · CNS Drugs · doi:10.1007/s40263-024-01126-8 · Cited by 6

Tratamento Farmacológico da Síndrome de Abstinência Alcoólica

Teixeira, J. (2021) · Acta Médica Portuguesa · doi:10.20344/amp.15799 · Cited by 9

Alcohol use disorder: Recognition, testing, and initial management strategies

Boschuetz, N., & German, M. N. (2023) · Clinical Liver Disease · doi:10.1097/cld.0000000000000062 · Cited by 6

Preventive hepatology at AIIMS Rishikesh: Delivering comprehensive and integrated care for liver diseases in Northern state of India

Bhadoria, A. S., Saxena, G., Pandey, P., Mehndiratta, A., Sadasivan, A., Gupta, R., Singh, P., & Nundy, S. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1536_23 · Cited by 6

ADHD and Alcohol Use Disorder: Optimizing Screening and Treatment in Co-occurring Conditions

Hernández, M., LEVIN, F. R., & Campbell, A. N. C. (2025) · CNS Drugs · doi:10.1007/s40263-025-01168-6 · Cited by 6

Optimal Dose of Baclofen for the Treatment of Alcohol Use Disorder: A Systematic Review and Dose-Response Meta-analysis

Kotake, K., So, R., Hashimoto, N., Imai, E., Kaneko, T., Banno, M., & Furukawa, Y. (2025) · CNS Drugs · doi:10.1007/s40263-025-01188-2 · Cited by 5

Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial

Schacht, J. P., Sakai, J. T., Raymond, K. M., & Shelton, R. (2026) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20260003 · Cited by 8

Combined pharmacological and psychosocial interventions for alcohol use disorder

Agabio, R., Camposeragna, A., Saulle, R., Krupchanka, D., Leggio, L., & Minozzi, S. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015673 · Cited by 5

Kynurenine metabolite changes in individuals with alcohol use disorder: A systematic review and meta-analysis

Wang, Z., Huang, S., Li, L., Wen, Y., & Shang, D. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110821 · Cited by 5

Use of Phosphatidylethanol Testing in Patients With Liver Disease

Khanna, S., Shah, N. L., & Argo, C. K. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002537 · Cited by 5

Psychiatric Comorbidity in Major Depressive Disorder

Kim, J., & Schwartz, T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-58131-8.00007-0 · Cited by 1

Evidence of subgroup differences in meta‐analyses evaluating medications for alcohol use disorder: An umbrella review

Wallach, J. D., Glick, L. R., Gueorguieva, R. V., & O’Malley, S. S. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15229 · Cited by 5

Implementation and analysis of a multifaceted intervention for alcohol use disorder from a single academic urban emergency department

Duvalyan, E., Falade, I. O., Fan, W., Foe, M., Mvemba, A., Zussman, J. W., Geier, C., LeSaint, K. T., & Graglia, S. (2024) · Academic Emergency Medicine · doi:10.1111/acem.14860 · Cited by 5

Potential Link Between Exercise and N-Methyl-D-Aspartate Glutamate Receptors in Alcohol Use Disorder: Implications for Therapeutic Strategies

Sedhom, S., Hammond, N., Thanos, K. Z., Blum, K., Elman, I., Bowirrat, A., Dennen, C. A., & Thanos, P. K. (2024) · Psychology Research and Behavior Management · doi:10.2147/prbm.s462403 · Cited by 6

Advancements in addressing drug dependence: A review of promising therapeutic strategies and interventions

Guida, C. R., Maia, J. M., Ferreira, L. F. R., Rahdar, A., Branco, L. G. S., & Soriano, R. N. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111070 · Cited by 6

Pharmacological treatments for alcohol dependence: Evidence on uptake, inequalities and comparative effectiveness from a UK population‐based cohort

Manca, F., Zhang, L., Fitzgerald, N., Ho, F. K. W., Innes, H. A., Jani, B., Katikireddi, S. V., McAuley, A., Sharp, C., & Lewsey, J. (2024) · Drug and Alcohol Review · doi:10.1111/dar.13841 · Cited by 4

Eosinophilic pustular folliculitis due to naltrexone: A case report

Smith, S., Cernaro, N., & Tonti, E. (2022) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2022.07.007 · Cited by 4

Zingiber officinale (Ginger) Methanol Extract Abates Kidney Dysfunction in Mice Co-exposed to Sub-chronic Alcohol Intoxication and Post-traumatic Stress Disorder

Adebayo, O. G., Ben‐Azu, B., Akpofure, E., Emmanuel, M. U., Wopara, I., Aduema, W., Adedayo, L. D., & Abeje, J. I. (2023) · Clinical Complementary Medicine and Pharmacology · doi:10.1016/j.ccmp.2023.100116 · Cited by 4

Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations

Bahji, A., Crockford, D. N., Brasch, J. S., Schütz, C. G., Buckley, L., Danilewitz, M., Dubreucq, S., Mak, M. S. B., & George, T. P. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241231128 · Cited by 4

Improvement in inpatient discharge planning for patients with alcohol use disorder with the implementation of a team-based multidisciplinary workflow

Abiri, P., Jeong, I. S. D., Verdell, A., Shah, S., Entabi, R., & Nguyen, H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306066 · Cited by 4

Clinician Prescribing Practices Involving Medications for Alcohol Use Disorder

Kennedy‐Hendricks, A., Busch, A. B., Azeni, H., Horgan, C. M., Uscher‐Pines, L., Hodgkin, D., & Huskamp, H. A. (2024) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2024.11.006 · Cited by 4

Regaining control over alcohol intake but not abstinence on disulfiram medication, as a harm reduction approach: 2 case reports

Schallenberg, M., Pilhatsch, M., Petzold, J., Vogel, D., Zimmermann, U. S., & Spreer, M. (2024) · Addiction Science & Clinical Practice · doi:10.1186/s13722-024-00522-1 · Cited by 4

Safety of nalmefene for the treatment of alcohol use disorder: an update

López‐Pelayo, H., Zuluaga, P., Caballería, E., van den Brink, W., Mann, K. F., & Gual, A. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1707802 · Cited by 5

Pharmacological interventions for alcohol misuse in correctional settings: A systematic review

Slavin‐Stewart, C., Minhas, M., Turna, J., Brasch, J. S., Olagunju, A. T., Chaimowitz, G. A., & MacKillop, J. M. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14751 · Cited by 4

Identifying and Managing Eating Disorders in Persons Presenting for Addiction Treatment

Norris, T., Dahl, P., Jericho, M. C., & Crockford, D. (2021) · Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000129 · Cited by 4

Early treatment with thiamine and mortality among patients with alcohol use disorder who are hospitalized for pneumonia

Baron, S. W., Yu, P.-C., Imrey, P. B., Southern, W. N., Deshpande, A., & Rothberg, M. B. (2022) · Journal of Hospital Medicine · doi:10.1002/jhm.12895 · Cited by 4

Defining the psychiatric and financial burden of mental and substance use disorders in cancer patients

Baliga, S., Klamer, B. G., Palmer, J. D., Gregorio, S. W., Kale, S. S., Bonomi, M. R., Old, M. O., Rocco, J. W., & Blakaj, D. M. (2022) · Cancer Medicine · doi:10.1002/cam4.5548 · Cited by 4

Structured alcohol cessation support program versus current practice in acute alcoholic pancreatitis (PANDA): Study protocol for a multicentre cluster randomised controlled trial

Sissingh, N. J., Nagelhout, A., Besselink, M. G., Boermeester, M. A., Bouwense, S. A. W., Bruno, M. J., Fockens, P., Goudriaan, A. E., Rodríguez-Girondo, M., van Santvoort, H. C., et al. (2023) · Pancreatology · doi:10.1016/j.pan.2023.10.015 · Cited by 4

Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder

Holt, S. R. (2024) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000001345 · Cited by 4

Alcohol Use Disorder and Hepatitis C Prevention and Care in People Who Inject Drugs: The State of Play

Marcellin, F., Jaquet, A., Lazarus, J. V., Molina, P. E., & Carrieri, P. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1716343 · Cited by 4

Use of Disulfiram for Treatment of Alcohol Addiction in Patients With Psychotic Illness

Williams, J. B. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18070795 · Cited by 4

Practice guideline for the treatment of patients with substance use disorders: alcohol, cocaine, opioids. American Psychiatric Association

(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.11.1 · Cited by 88

Practice Guideline for the Treatment of Patients With Substance Use Disorders, Second Edition

(2007) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890423363.141077 · Cited by 172

American Psychiatric Association Practice Guidelines

Alarcón, R. D. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0107 · Cited by 112

American Psychiatric Association issues guidelines on treatment of substance use disorders.

(1996) · PubMed

Pharmacological treatment of alcohol use disorder.

Mason, B. J. (2019) · American Psychological Association eBooks · doi:10.1037/0000133-022 · Cited by 1